Lisinopril with Hydrochlorothiazide
- Product NDC
- 50090-2086
- 11-digit product format
- 500902086
- Labeler code
- 50090
- Product ID
- 50090-2086_a3c74d1e-c985-4bc5-b3e0-838d1f803136
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076265
- Marketing category
- ANDA
- Marketing start
- 2002-07-08
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-2086-0 | 2021-06-10 | C162847 | 48780-1 | 9d75b9d0-bb5a-f424-e053-dadaa90a57ce | 5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58 |
| 50090-2086-1 | 2021-06-10 | C162847 | 48780-1 | 9d75b9d0-bb5a-f424-e053-dadaa90a57ce | 5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58 |
| 50090-2086-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bb5a-f424-e053-dadaa90a57ce | 5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58 |
| 50090-2086-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bb5a-f424-e053-dadaa90a57ce | 5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-2086-0 | EA - Each | 50090-2086 | d8c0b8d7-fb11-4d30-bf4d-5a9e83cd44f0 | 1 | 2019-02-13 |
| 50090-2086-1 | EA - Each | 50090-2086 | 38263845-c6ad-4f84-b128-d83115a88aac | 1 | 2019-02-13 |